Titan Pharmaceuticals Investor Alert: Kahn Swick & Foti Investigates Merger with KE Sdn. Bhd.

Kahn Swick & Foti, LLC, a law firm led by former Louisiana Attorney General Charles C. Foti, is investigating Titan Pharmaceuticals' proposed merger with KE Sdn. Bhd. The firm is seeking to determine if the merger and process leading to it are adequate and fair to shareholders. If you have any concerns, you can contact Lewis S. Kahn at 855-768-1857 or visit their website for more information.

Kahn Swick & Foti, LLC, a law firm led by former Louisiana Attorney General Charles C. Foti, has initiated an investigation into Titan Pharmaceuticals, Inc.'s (TTNP) proposed merger with KE Sdn. Bhd. The firm is examining whether the merger and the process leading to it are adequate and fair to shareholders.

Under the terms of the proposed merger, the existing security holders of KE and Titan expect to own approximately 86.7% and 13.3%, respectively, of the outstanding shares of the combined company. The investigation concerns whether the Titan Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Lewis S. Kahn, Managing Partner of Kahn Swick & Foti, LLC, has stated that the firm is seeking to determine whether the consideration and the process that led to the merger are adequate or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn toll free at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-ttnp/ to learn more.

For further information, please visit Kahn Swick & Foti, LLC's website at https://www.ksfcounsel.com.

References:
[1] https://www.tradingview.com/news/reuters.com,2025-07-30:newsml_NFC2ncmLr:0-shareholder-notice-brodsky-smith-announces-an-investigation-of-titan-pharmaceuticals-inc-ttnp/
[2] https://www.marketscreener.com/news/performant-healthcare-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-ce7c5ed8d088f626
[3] https://www.morningstar.com/news/business-wire/20250805862253/hillevax-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-hillevax-inc-hlvx